Logo
Home
About
Articles
FAQ
Sign In
Search
Join the mailing list
Logo
Search
Home
About
Articles
FAQ
Sign In
Join the mailing list
Medical Costs

4 questions on the future of employer-sponsored healthcare

What is keeping employers up at night going into 2025? A conversation with Chris Michalak

Christina Farr
Mar 27, 2025
4 questions on the future of employer-sponsored healthcare

Why the Hinge Health IPO is so important for digital health

A few thoughts...

Christina Farr
Mar 11, 2025
Paid
Why the Hinge Health IPO is so important for digital health

4 questions on President Trump and IVF

I caught up with Conceivable Life Sciences’ Joshua Abram to understand the political landscape and its impact on reproductive health

Christina Farr
Feb 21, 2025
4 questions on President Trump and IVF

The massive opportunity in women's longevity

State of the union, and where we go from here

Leslie Schrock
Feb 6, 2025
The massive opportunity in women's longevity

How are employers going to pay for cell and gene therapies?

Let’s get real about the alliance between U.S. health care and employment

Christina Farr
Jan 20, 2025
How are employers going to pay for cell and gene therapies?

Is it possible for employers to keep costs down and cover GLP-1s?

That’s the question of the moment - and we explore it in-depth.

Christina Farr, +1
Nov 1, 2024
Is it possible for employers to keep costs down and cover GLP-1s?

Interested in sponsoring Second Opinion?
Reach out!

I consent to receive newsletters via email. Terms of use and Privacy policy.